Wedbush Starts Unum Therapeutics (UMRX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
SunTrust Robinson Humphrey Starts Unum Therapeutics (UMRX) at Buy
April 23, 2018 6:22 AM EDTSunTrust Robinson Humphrey initiates coverage on Unum Therapeutics (NASDAQ: UMRX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Unum Therapeutics click here. For more ratings news on Unum Therapeutics click here.
Shares of Unum Therapeutics closed at $11.98 Friday.
... MoreMorgan Stanley Starts Unum Therapeutics (UMRX) at Overweight
April 23, 2018 5:35 AM EDTMorgan Stanley initiates coverage on Unum Therapeutics (NASDAQ: UMRX) with a Overweight rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Unum Therapeutics click here. For more ratings news on Unum Therapeutics click here.
Shares of Unum Therapeutics closed at $11.98 Friday.
... MoreCowen Starts Unum Therapeutics (UMRX) at Market Perform
April 23, 2018 5:34 AM EDTCowen initiates coverage on Unum Therapeutics (NASDAQ: UMRX) with a Market Perform rating.
Analyst Eric Schmidt comments "Relative to 1st-gen T cell therapies, Unums Antibody-Coupled T cell Receptor (ACTR) platform seeks to provide a universal approach with the potential for greater tunability. While... More
